跳至主要内容
临床试验/NCT02052804
NCT02052804已完成不适用

Understanding and Treating Heart Failure With Preserved Ejection Fraction: Novel Mechanisms, Diagnostics and Potential Therapeutics

University of Alberta2 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2009年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
700
试验地点
2
主要终点
Percent of patients meeting new diagnostic criteria for HFpEF

研究概览

简要总结

The objectives of this study are: 1) to design new diagnostic criteria used to accurately define heart failure with preserved ejection fraction (HFpEF); 2) to better define the risk factors associated with HFpEF; 3) to elucidate the clinical, cellular and molecular mechanisms involved with the development and progression of HFpEF; 4) to design and test new therapeutic strategies for patients with HFpEF.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Group 1 No clinically overt heart failure
  • Group 2 Known coronary artery disease
  • Group 3 Known heart failure with preserved ejection fraction
  • Group 4 Known heart failure with reduced ejection fraction
  • Group 5 Healthy age-matched controls

排除标准

  • Age <18 years
  • Known malignancy with expected survival <1 year
  • Pregnant or recent pregnancy <6 months
  • Recent event (<2 weeks since Acute Coronary Syndrome, Heart failure or other admission
  • Severe mitral or aortic stenosis

结局指标

主要结局

Percent of patients meeting new diagnostic criteria for HFpEF

时间窗: Up to 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Justin Ezekowitz

Associate Professor, University of Alberta; Director, Heart Function Clinic- Mazankowski Alberta Heart Institute

University of Alberta

研究点 (2)

Loading locations...

相似试验

Understanding and Treating Heart Failure With... | 临床试验